Trial Profile
A Phase I Randomised, Double-Blind, Placebo-Controlled, Ascending Single ' Repeat-Dose Study of Safety, Tolerability ' Pharmacokinetics of CTX-4430 When Administered Orally to Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Acebilustat (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions; First in man
- Sponsors Celtaxsys
- 28 Oct 2016 According to a Celtaxsys media release the result from this trial will be published in the journal Clinical and Translational Science (CTS), a publication of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
- 16 Apr 2014 New trial record